Darren O Brien
Director/Board Member at AEON Biopharma Sub, Inc.
Profile
Darren O Brien is currently a Director at AEON Biopharma Sub, Inc. and holds Managing Director & Partner position at Sailing Capital Advisors Hong Kong Ltd and Director position at Alphaeon 1 LLC.
He previously worked as a Director at Sailing Innovation (UK) Ltd.
Darren O Brien active positions
Companies | Position | Start |
---|---|---|
Sailing Capital Advisors Hong Kong Ltd
Sailing Capital Advisors Hong Kong Ltd Investment ManagersFinance Sailing Capital Advisors Hong Kong Ltd (Sailing Capital Advisors) is a private equity subsidiary of Sailing Capital Management Co Ltd founded in 2012. The firm is headquartered in Wan Chain, Hong Kong. | Private Equity Investor | - |
Alphaeon 1 LLC
Alphaeon 1 LLC Financial ConglomeratesFinance Alphaeon 1 LLC operates as investment holding company. The company was founded in 2020 and is headquartered in Newport Beach, CA. | Director/Board Member | - |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Director/Board Member | 23/07/2023 |
Former positions of Darren O Brien
Companies | Position | End |
---|---|---|
Sailing Innovation (UK) Ltd.
Sailing Innovation (UK) Ltd. Financial ConglomeratesFinance Sailing Innovation (UK) Ltd. operates as a British dormant company. The private company is based in London, UK. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
Sailing Capital Advisors Hong Kong Ltd
Sailing Capital Advisors Hong Kong Ltd Investment ManagersFinance Sailing Capital Advisors Hong Kong Ltd (Sailing Capital Advisors) is a private equity subsidiary of Sailing Capital Management Co Ltd founded in 2012. The firm is headquartered in Wan Chain, Hong Kong. | Finance |
Sailing Innovation (UK) Ltd.
Sailing Innovation (UK) Ltd. Financial ConglomeratesFinance Sailing Innovation (UK) Ltd. operates as a British dormant company. The private company is based in London, UK. | Finance |
Alphaeon 1 LLC
Alphaeon 1 LLC Financial ConglomeratesFinance Alphaeon 1 LLC operates as investment holding company. The company was founded in 2020 and is headquartered in Newport Beach, CA. | Finance |
- Stock Market
- Insiders
- Darren O Brien